NEW MJ NEWS

Jushi Holdings Inc. Announces Participation in Upcoming Conference in August 2022

Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Kim Eastman, Vice President of Manufacturing, will be participating in the Cannabis Conference Presented by Cannabis Business Times at Paris Las Vegas Hotel & Casino in Las Vegas, Nevada. Ms. Eastman is scheduled to participate in a panel discussion entitled, “How to Build Out and Set Up an Extraction Facility” beginning at 10:00 a.m. PT on Tuesday, August 23, 2022. To register for the event, please click here.

For more information about the conference, please contact Jushi’s Investor Relations at investors@jushico.com.

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, Twitter, and LinkedIn.

For further information, please contact:

Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations
561-281-0247
investors@jushico.com

Media Contact:
Ellen Mellody
570-209-2947
ellen@mattio.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Village Farms International, Inc. (VFF) to Report First Quarter 2023 Financial Results on Wednesday, May 10

Village Farms International to Report First Quarter 2023 Financial Results on Wednesday,…

AbbVie Inc. (ABBV) Advances Immunology Pipeline with First Patient Dosed in Global Phase 3 Trial of Upadacitinib (RINVOQ®)

AbbVie Advances Immunology Pipeline with First Patient Dosed in Global Phase 3…

$ICBU announces the sale of OMI and PCI Heartscan

iMD Companies announces the sale of OMI and PCI Heartscan for the…

Tilray Brands, Inc. (TLRY) Launches Special-Edition 420 IPA in Partnership With the Georgia Aquarium

SweetWater Brewing Company Launches Special-Edition 420 IPA in Partnership With the Georgia…